North America Alopecia Areata Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	247 Pages	Data Bridge Market Research	July, 2024	DAABD19176078

Best Price Guarantee
Price	from $3,500
Length	247 Pages
Publisher	Data Bridge Market Research
Published Date	July, 2024
SKU	DAABD19176078

North America Alopecia Areata Market

North America alopecia areata market is expected to reach USD 7,257.43 million by 2031 from USD 3,916.24 million in 2023, growing with a CAGR of 8.0% in the forecast period of 2024 to 2031.
Market Segmentation:
North America Alopecia Areata Market, By Disease Type (Alopecia Areata (Patchy), Alopecia Areata Totalis, Alopecia Areata Universalis, and Others), Cause (Non-Genetic and Genetic), Type (Treatment and Diagnosis), Age Group (Below 18 Years, 18-50 Years, and Above 50 Years), Gender (Female and Male), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031
Overview of North America Alopecia Areata Market Dynamics:
Driver
• Increase in geriatric population
Restraint
• Side effects associated with the available hair loss treatment therapies
Opportunity
• Development and technological advancements in hair treatment medical devices
Market Players:
The key market players operating in the North America alopecia areata market are listed below:
• Pfizer Inc.
• Dr. Reddy's Laboratories Ltd.
• Lilly
• Sun Pharmaceutical Industries Ltd.
• GSK plc.
• Johnson & Johnson Consumer Inc.
• Lupin
• Croma-Pharma GmbH
• Viviscal Limited (A Subsidiary of Church & Dwight Co.)
• AdvaCare Pharma
• Wellona Pharma
• Teva Pharmaceuticals USA, Inc.
• Croma-Pharma GmbH
• Reistone Biopharma

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. This publisher does offer titles that are created upon receipt of order.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of North America Alopecia Areata Market; 1.4 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Therapeutics Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Market End User Coverage Grid; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insight: 4.1 Pestal Analysis; 4.2 Porters Analysis; 4.3 Patent Analysis; 4.4 Product Sales By Year; 4.4.1 Product Sales By Year, 2024; 4.4.2 Product Sales By Year, 2023; 4.4.3 Product Sales By Year, 2022; 4.4.4 Product Sales By Year, 2021; 4.4.5 Product Sales By Year, 2020; 4.4.6 Product Sales By Year, 2019
5 North America Alopecia Treatment Areata Market: Regulations
6 Market Overview: 6.1 Drivers; 6.1.1 Increase In Geriatric Population; 6.1.2 Rise In Prevalence Of Alopecia Conditions; 6.1.3 Increase In Prevalence Of Chemotherapy Induced Alopecia; 6.1.4 Increasing Level Of Stress; 6.1.5 Changing Lifestyles; 6.2 Restraints; 6.2.1 Side Effects Associated With The Available Hair Loss Treatment Therapies; 6.2.2 High Cost Of Therapies; 6.2.3 Recall Of Drug Or Medication For Hair Loss Treatment; 6.3 Opportunities; 6.3.1 Development And Technological Advancements In Hair Treatment Medical Devices; 6.3.2 Rising Disposable Income; 6.3.3 Strategic Initiatives By The Market Players; 6.3.4 Increasing Awareness Regarding The Alopecia (Hair Loss); 6.4 Challenges; 6.4.1 Patent Expiration; 6.4.2 Existence Of Alternative Treatment Options
7 North America Alopecia Areata Market, By Type: 7.1 Overview; 7.2 Treatment; 7.2.1 Medical Treatment; 7.2.1.1 Localized Therapies; 7.2.1.1.1 Minoxidil; 7.2.1.1.2 Intralesional Corticosteroids; 7.2.1.1.3 Topical Corticosteroids; 7.2.1.1.4 Topical Immunotherapy; 7.2.1.1.5 Topical Finasteride; 7.2.1.1.6 Anthralin; 7.2.1.1.7 Prostaglandin Analogs; 7.2.1.1.8 Others; 7.2.1.2 Systemic Therapies; 7.2.1.2.1 Jak Inihibitors; 7.2.1.2.2 Oral Corticosteroids; 7.2.1.2.3 Oral Finasteride; 7.2.1.2.4 Methotrexate; 7.2.1.2.5 Cyclosporin; 7.2.1.2.6 Micronutrient Supplements; 7.2.1.2.7 Others; 7.2.1.3 By Medication Type; 7.2.1.3.1 Branded; 7.2.1.3.2 Generic; 7.2.1.4 By Prescription Mode; 7.2.1.4.1 Prescription Based; 7.2.1.4.2 Otc; 7.2.1.5 By Form; 7.2.1.5.1 Topical; 7.2.1.5.2 Oral; 7.2.1.5.3 Parenteral; 7.2.1.5.4 Others; 7.2.2 Medical Devices; 7.2.2.1 Laser Treatment; 7.2.2.2 High Power Led; 7.2.3 Herbal Treatment; 7.2.3.1 Aloe Barbadensis; 7.2.3.2 Phyllanthus Embelica; 7.2.3.3 Prunus Amygdalus; 7.2.3.4 Avena Sativa; 7.2.3.5 Amaranthus Spinosus; 7.2.3.6 Cajanus Cajan; 7.2.3.7 Daucus Carota; 7.2.3.8 Juglans Regia; 7.2.3.9 Bacopa Monniere; 7.2.3.10 Medicago Sativa; 7.2.3.11 Lactuca Sativa; 7.2.3.12 Pelvetia Canaliculata; 7.2.3.13 Others; 7.2.4 Others; 7.2.4.1 Surgical Hair Restoration; 7.2.4.1.1 Hair Transplantation; 7.2.4.1.2 Scalp Flaps; 7.2.4.1.3 Alopecia Reduction (Ar); 7.2.4.2 Cosmetics; 7.2.4.2.1 Microneedling; 7.2.4.2.2 Mesotherapy; 7.2.4.2.3 Stem Cell Therapy; 7.2.4.2.4 Others; 7.2.4.3 By End User; 7.2.4.3.1 Dermatology And Trichology Clinic; 7.2.4.3.2 Hospital; 7.2.4.3.3 Home Healthcare; 7.2.4.3.4 Others; 7.2.4.4 By Distribution Channel; 7.2.4.4.1 Hospital Pharmacies; 7.2.4.4.2 Retail Pharmacies; 7.2.4.4.3 Online Pharmacies; 7.3 Diagnosis
8 North America Alopecia Areata Market, By Cause: 8.1 Overview; 8.2 Non Genetic; 8.3 Genetic
9 North America Alopecia Areata Market, By Disease Type: 9.1 Overview; 9.2 Alopecia Areata (Patchy); 9.2.1 Single Patch; 9.2.2 Double Patch; 9.2.3 Multi Patch; 9.3 Alopecia Areata Totalis; 9.4 Alopecia Areata Universalis; 9.5 Others; 9.5.1 Diffuse Alopecia Areata; 9.5.2 Ophiasis Alopecia
10 North America Alopecia Areata Market, By Age Group: 10.1 Overview; 10.2 Below 18 Years; 10.3 18-50 Years; 10.4 Above 50 Years
11 North America Alopecia Areata Market, By Gender: 11.1 Overview; 11.2 Female; 11.3 Male
12 North America Alopecia Areata Market, By Region: 12.1 North America; 12.1.1 U.S; 12.1.2 Canada; 12.1.3 Mexico
13 North America Alopecia Areata Market: Company Landscape: 13.1 Company Share Analysis: North America
14 Swot Analysis
15 Company Profiles: 15.1 Pfizer Inc.; 15.1.1 Company Snapshot; 15.1.2 Revenue Analysis; 15.1.3 Company Share Analysis; 15.1.4 Product Portfolio; 15.1.5 Recent Developments; 15.2 Dr. Reddy’s Laboratories Ltd.; 15.2.1 Company Snapshot; 15.2.2 Revenue Analysis; 15.2.3 Company Share Analysis; 15.2.4 Product Portfolio; 15.2.5 Recent Developments; 15.3 Lilly; 15.3.1 Company Snapshot; 15.3.2 Revenue Analysis; 15.3.3 Company Share Analysis; 15.3.4 Product Portfolio; 15.3.5 Recent Developments; 15.4 Sun Pharmaceutical Industries Ltd.; 15.4.1 Company Snapshot; 15.4.2 Revenue Analysis; 15.4.3 Company Share Analysis; 15.4.4 Product Portfolio; 15.4.5 Recent Developments; 15.5 Gsk Plc.; 15.5.1 Company Snapshot; 15.5.2 Revenue Analysis; 15.5.3 Company Share Analysis; 15.5.4 Product Portfolio; 15.5.5 Recent Developments; 15.6 Abbvie Inc.; 15.6.1 Company Snapshot; 15.6.2 Revenue Analysis; 15.6.3 Product Portfolio; 15.6.4 Recent Developments; 15.7 Advacare Pharma; 15.7.1 Company Snapshot; 15.7.2 Product Portfolio; 15.7.3 Recent Developments; 15.8 Croma-pharma Gmbh; 15.8.1 Company Snapshot; 15.8.2 Product Portfolio; 15.8.3 Recent Developments; 15.9 Follicum Ab; 15.9.1 Company Snapshot; 15.9.2 Product Portfolio; 15.9.3 Recent Developments; 15.10 Teva Pharmaceuticals Usa, Inc.; 15.10.1 Company Snapshot; 15.10.2 Revenue Analysis; 15.10.3 Product Portfolio; 15.10.4 Recent Developments; 15.11 Viviscal Limited (A Subsidiary Of Church & Dwight Co.); 15.11.1 Company Snapshot; 15.11.2 Product Portfolio; 15.11.3 Recent Developments; 15.12 Wellona Pharma; 15.12.1 Company Snapshot; 15.12.2 Product Portfolio; 15.12.3 Recent Developments; 15.13 Johnson & Johnson Services, Inc; 15.13.1 Company Snapshot; 15.13.2 Revenue Analysis; 15.13.3 Product Portfolio; 15.13.4 Recent Developments; 15.14 Nanogen; 15.14.1 Company Snapshot; 15.14.2 Product Portfolio; 15.14.3 Recent Developments; 15.15 Vitabiotics Ltd.; 15.15.1 Company Snapshot; 15.15.2 Product Portfolio; 15.15.3 Recent Developments; 15.16 Lupin; 15.16.1 Company Snapshot; 15.16.2 Revenue Analysis; 15.16.3 Product Portfolio; 15.16.4 Recent Developments; 15.17 Reistone Biopharma; 15.17.1 Company Snapshot; 15.17.2 Product Portfolio; 15.17.3 Recent Developments; 15.18 Technoderma Medicines Inc.; 15.18.1 Company Snapshot; 15.18.2 Product Portfolio; 15.18.3 Recent Developments
16 Questionnaire
17 Related Reports: Table 1 Incidence Of Alopecia Associated To The Main Chemotherapic Drug Categories; Table 2 North America Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 3 North America Treatment In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 4 North America Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 5 North America Medical Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 6 North America Localized Therapies In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 7 North America Systemic Therapies In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 8 North America Medical Treatment In Alopecia Areata Market, By Medication Type, 2022-2031 (Usd Thousand); Table 9 North America Medical Treatment In Alopecia Areata Market, By Prescription Mode, 2022-2031 (Usd Thousand); Table 10 North America Medical Treatment In Alopecia Areata Market, By Form, 2022-2031 (Usd Thousand); Table 11 North America Medical Devices In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 12 North America Herbal Therapies In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 13 North America Others In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 14 North America Surgical Hair Restoration In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 15 North America Cosmetics In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 16 North America Treatment In Alopecia Areata Market, By End User, 2022-2031 (Usd Thousand); Table 17 North America Hospital In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 18 North America Treatment In Alopecia Areata Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 19 North America Diagnosis In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 20 North America Diagnosis In Alopecia Areata Market, By Type,2022-2031; Table 21 North America Alopecia Areata Market, By Cause, 2022-2031 (Usd Thousand); Table 22 North America Non-genetic In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 23 North America Genetic In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 24 North America Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 25 North America Alopecia Areata (Patchy) In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 26 North America Alopecia Areata (Patchy) In Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 27 North America Alopecia Areata Totalis In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 28 North America Alopecia Areata Universalis In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 29 North America Others In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 30 North America Others In Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 31 North America Alopecia Areata Market, By Age Group, 2022-2031 (Usd Thousand); Table 32 North America Below 18 Years In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 33 North America 18-50 Years In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 34 North America Above 50 Years Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 35 North America Alopecia Areata Market, By Gender, 2022-2031 (Usd Thousand); Table 36 North America Female In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 37 North America Male In Alopecia Areata Market, By Region, 2022-2031 (Usd Thousand); Table 38 North America Alopecia Areata Market, By Country, 2022-2031 (Usd Thousand); Table 39 North America Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 40 North America Alopecia Areata (Patchy) In Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 41 North America Others In Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 42 North America Alopecia Areata Market, By Cause, 2022-2031 (Usd Thousand); Table 43 North America Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 44 North America Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 45 North America Medical Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 46 North America Localized Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 47 North America Systemic Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 48 North America Medical Treatment In Alopecia Areata Market, By Medication Type, 2022-2031 (Usd Thousand); Table 49 North America Medical Treatment In Alopecia Areata Market, By Prescription Mode, 2022-2031 (Usd Thousand); Table 50 North America Medical Treatment In Alopecia Areata Market, By Form, 2022-2031 (Usd Thousand); Table 51 North America Medical Devices In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 52 North America Herbal Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 53 North America Others In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 54 North America Surgical Hair Restoration In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 55 North America Cosmetics In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 56 North America Diagnosis In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 57 North America Alopecia Areata Market, By Age Group, 2022-2031 (Usd Thousand); Table 58 North America Alopecia Areata Market, By Gender, 2022-2031 (Usd Thousand); Table 59 North America Treatment In Alopecia Areata Market, By End User, 2022-2031 (Usd Thousand); Table 60 North America Hospital In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 61 North America Treatment In Alopecia Areata Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 62 U.S. Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 63 U.S. Alopecia Areata (Patchy) In Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 64 U.S. Others In Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 65 U.S. Alopecia Areata Market, By Cause, 2022-2031 (Usd Thousand); Table 66 U.S. Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 67 U.S. Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 68 U.S. Medical Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 69 U.S. Localized Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 70 U.S. Systemic Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 71 U.S. Medical Treatment In Alopecia Areata Market, By Medication Type, 2022-2031 (Usd Thousand); Table 72 U.S. Medical Treatment In Alopecia Areata Market, By Prescription Mode, 2022-2031 (Usd Thousand); Table 73 U.S. Medical Treatment In Alopecia Areata Market, By Form, 2022-2031 (Usd Thousand); Table 74 U.S. Medical Devices In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 75 U.S. Herbal Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 76 U.S. Others In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 77 U.S. Surgical Hair Restoration In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 78 U.S. Cosmetics In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 79 U.S. Diagnosis In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 80 U.S. Alopecia Areata Market, By Age Group, 2022-2031 (Usd Thousand); Table 81 U.S. Alopecia Areata Market, By Gender, 2022-2031 (Usd Thousand); Table 82 U.S. Treatment In Alopecia Areata Market, By End User, 2022-2031 (Usd Thousand); Table 83 U.S. Hospital In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 84 U.S. Treatment In Alopecia Areata Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 85 Canada Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 86 Canada Alopecia Areata (Patchy) In Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 87 Canada Others In Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 88 Canada Alopecia Areata Market, By Cause, 2022-2031 (Usd Thousand); Table 89 Canada Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 90 Canada Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 91 Canada Medical Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 92 Canada Localized Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 93 Canada Systemic Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 94 Canada Medical Treatment In Alopecia Areata Market, By Medication Type, 2022-2031 (Usd Thousand); Table 95 Canada Medical Treatment In Alopecia Areata Market, By Prescription Mode, 2022-2031 (Usd Thousand); Table 96 Canada Medical Treatment In Alopecia Areata Market, By Form, 2022-2031 (Usd Thousand); Table 97 Canada Medical Devices In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 98 Canada Herbal Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 99 Canada Others In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 100 Canada Surgical Hair Restoration In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 101 Canada Cosmetics In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 102 Canada Diagnosis In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 103 Canada Alopecia Areata Market, By Age Group, 2022-2031 (Usd Thousand); Table 104 Canada Alopecia Areata Market, By Gender, 2022-2031 (Usd Thousand); Table 105 Canada Treatment In Alopecia Areata Market, By End User, 2022-2031 (Usd Thousand); Table 106 Canada Hospital In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 107 Canada Treatment In Alopecia Areata Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 108 Mexico Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 109 Mexico Alopecia Areata (Patchy) In Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 110 Mexico Others In Alopecia Areata Market, By Disease Type, 2022-2031 (Usd Thousand); Table 111 Mexico Alopecia Areata Market, By Cause, 2022-2031 (Usd Thousand); Table 112 Mexico Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 113 Mexico Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 114 Mexico Medical Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 115 Mexico Localized Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 116 Mexico Systemic Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 117 Mexico Medical Treatment In Alopecia Areata Market, By Medication Type, 2022-2031 (Usd Thousand); Table 118 Mexico Medical Treatment In Alopecia Areata Market, By Prescription Mode, 2022-2031 (Usd Thousand); Table 119 Mexico Medical Treatment In Alopecia Areata Market, By Form, 2022-2031 (Usd Thousand); Table 120 Mexico Medical Devices In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 121 Mexico Herbal Treatment In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 122 Mexico Others In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 123 Mexico Surgical Hair Restoration In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 124 Mexico Cosmetics In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 125 Mexico Diagnosis In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 126 Mexico Alopecia Areata Market, By Age Group, 2022-2031 (Usd Thousand); Table 127 Mexico Alopecia Areata Market, By Gender, 2022-2031 (Usd Thousand); Table 128 Mexico Treatment In Alopecia Areata Market, By End User, 2022-2031 (Usd Thousand); Table 129 Mexico Hospital In Alopecia Areata Market, By Type, 2022-2031 (Usd Thousand); Table 130 Mexico Treatment In Alopecia Areata Market, By Distribution Channel, 2022-2031 (Usd Thousand); Figure 1 North America Alopecia Areata Market: Segmentation; Figure 2 North America Alopecia Areata Market: Data Triangulation; Figure 3 North America Alopecia Areata Market: Droc Analysis; Figure 4 North America Alopecia Areata Market: North America Vs Regional Market Analysis; Figure 5 North America Alopecia Areata Market: Company Research Analysis; Figure 6 North America Alopecia Areata Market: Multivariate Modelling; Figure 7 North America Alopecia Areata Market: Interview Demographics; Figure 8 North America Alopecia Areata Market: Dbmr Market Position Grid; Figure 9 North America Alopecia Areata Market: Vendor Share Analysis; Figure 10 North America Alopecia Areata Market: Market End User Coverage Grid; Figure 11 North America Alopecia Areata Market: Segmentation; Figure 12 Executive Summary Of North America Alopecia Areata Market-; Figure 13 Strategic Decisions; Figure 14 Segmental Comparison Of North America Alopecia Areata Market; Figure 15 Rise In Prevalence Of Alopecia Conditions, Increase In Prevalence Of Chemotherapy Induced Alopecia, Increasing Level Of Stress And Changing Lifestyles Are Driving The North America Alopecia Areata Market In The Forecast Period Of 2024 To 2031; Figure 16 Alopecia Areata (Patchy) Segment Is Expected To Account For The Largest Share Of The North America Alopecia Areata Market In 2024 & 2031; Figure 17 Drivers, Restraints, Opportunities And Challenges Of North America Alopecia Areata Market; Figure 18 North America Alopecia Areata Market: By Type, 2023; Figure 19 North America Alopecia Areata Market: By Type, 2024-2031 (Usd Thousand); Figure 20 North America Alopecia Areata Market: By Type, Cagr (2024-2031); Figure 21 North America Alopecia Areata Market: By Type, Lifeline Curve; Figure 22 North America Alopecia Areata Market: By Cause, 2023; Figure 23 North America Alopecia Areata Market: By Cause, 2024-2031 (Usd Thousand); Figure 24 North America Alopecia Areata Market: By Cause, Cagr (2024-2031); Figure 25 North America Alopecia Areata Market: By Cause, Lifeline Curve; Figure 26 North America Alopecia Areata Market: By Disease Type 2023; Figure 27 North America Alopecia Areata Market: By Disease Type, 2024-2031 (Usd Thousand); Figure 28 North America Alopecia Areata Market: By Disease Type, Cagr (2024-2031); Figure 29 North America Alopecia Areata Market: By Disease Type, Lifeline Curve; Figure 30 North America Alopecia Areata Market: By Age Group, 2023; Figure 31 North America Alopecia Areata Market: By Age Group, 2024-2031 (Usd Thousand); Figure 32 North America Alopecia Areata Market: By Age Group, Cagr (2024-2031); Figure 33 North America Alopecia Areata Market: By Age Group, Lifeline Curve; Figure 34 North America Alopecia Areata Market: By Gender, 2023; Figure 35 North America Alopecia Areata Market: By Gender, 2024-2031 (Usd Thousand); Figure 36 North America Alopecia Areata Market: By Gender, Cagr (2024-2031); Figure 37 North America Alopecia Areata Market: By Gender, Lifeline Curve; Figure 38 North America Alopecia Areata Market: Snapshot (2023); Figure 39 North America Alopecia Areata Market: Company Share 2023 (%)